[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20120644T1 - Farmaceutski pripravak - Google Patents

Farmaceutski pripravak Download PDF

Info

Publication number
HRP20120644T1
HRP20120644T1 HRP20120644AT HRP20120644T HRP20120644T1 HR P20120644 T1 HRP20120644 T1 HR P20120644T1 HR P20120644A T HRP20120644A T HR P20120644AT HR P20120644 T HRP20120644 T HR P20120644T HR P20120644 T1 HRP20120644 T1 HR P20120644T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparation
pharmaceutical composition
agent
preparation according
group containing
Prior art date
Application number
HRP20120644AT
Other languages
English (en)
Croatian (hr)
Inventor
Sumida Shun-Ichiro
Ishikawa Shinichi
Original Assignee
Otsuka Pharmaceutical Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co. filed Critical Otsuka Pharmaceutical Co.
Publication of HRP20120644T1 publication Critical patent/HRP20120644T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20120644AT 2008-06-19 2012-08-08 Farmaceutski pripravak HRP20120644T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008160084 2008-06-19
PCT/JP2009/061553 WO2009154304A2 (en) 2008-06-19 2009-06-18 A pharmaceutical composition

Publications (1)

Publication Number Publication Date
HRP20120644T1 true HRP20120644T1 (hr) 2012-08-31

Family

ID=41334556

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120644AT HRP20120644T1 (hr) 2008-06-19 2012-08-08 Farmaceutski pripravak

Country Status (27)

Country Link
US (1) US20110124682A1 (ja)
EP (1) EP2285413B1 (ja)
JP (1) JP5441934B2 (ja)
KR (1) KR20110027786A (ja)
CN (1) CN102099056B (ja)
AR (1) AR072212A1 (ja)
AU (1) AU2009261101B2 (ja)
BR (1) BRPI0915427A2 (ja)
CA (1) CA2725487A1 (ja)
CO (1) CO6280502A2 (ja)
CY (1) CY1113214T1 (ja)
DK (1) DK2285413T3 (ja)
ES (1) ES2389583T3 (ja)
HK (1) HK1149496A1 (ja)
HR (1) HRP20120644T1 (ja)
IL (1) IL209329A (ja)
MX (1) MX2010013733A (ja)
MY (1) MY150558A (ja)
NZ (1) NZ589517A (ja)
PL (1) PL2285413T3 (ja)
PT (1) PT2285413E (ja)
RU (1) RU2538694C2 (ja)
SI (1) SI2285413T1 (ja)
TW (1) TWI495634B (ja)
UA (1) UA100164C2 (ja)
WO (1) WO2009154304A2 (ja)
ZA (1) ZA201008584B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201322982A (zh) * 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
TW201417814A (zh) * 2012-09-28 2014-05-16 Otsuka Pharma Co Ltd 包括瑞巴派特之醫藥組成物
KR101692578B1 (ko) 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
WO2015034008A1 (ja) * 2013-09-05 2015-03-12 大塚製薬株式会社 レバミピドの局所止血用途
JP6854587B2 (ja) * 2015-04-17 2021-04-07 ロート製薬株式会社 医薬製剤
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR20170039347A (ko) * 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
US11324829B2 (en) 2016-03-14 2022-05-10 Santen Pharmaceutical Co., Ltd. Antiseptic agent comprising meglumine or salt thereof
CN106491530B (zh) * 2016-12-13 2019-11-29 湖北远大天天明制药有限公司 一种眼用药物组合物
KR101840256B1 (ko) * 2017-09-21 2018-03-21 대우제약 주식회사 레바미피드를 함유하는 새로운 안구건조증 치료용 점안 조성물 및 이의 가용화 및 안정화 방법
KR101923519B1 (ko) 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR20200019451A (ko) 2018-08-14 2020-02-24 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
JP6744952B2 (ja) * 2019-05-28 2020-08-19 ロート製薬株式会社 眼科用組成物
KR102615076B1 (ko) 2021-07-14 2023-12-19 대우제약 주식회사 안정한 레바미피드 점안제의 대용량 제조 방법
KR102659338B1 (ko) 2023-05-18 2024-04-19 국제약품 주식회사 안구건조증 치료용 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
JP3093661B2 (ja) * 1995-10-12 2000-10-03 大塚製薬株式会社 眼疾患治療剤
AU1054301A (en) * 1999-11-11 2001-06-06 Takeda Chemical Industries Ltd. Nasal drops containing fused pyridazine derivatives
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
TWI363626B (en) * 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法

Also Published As

Publication number Publication date
KR20110027786A (ko) 2011-03-16
MY150558A (en) 2014-01-30
IL209329A0 (en) 2011-01-31
HK1149496A1 (en) 2011-10-07
AU2009261101A1 (en) 2009-12-23
DK2285413T3 (da) 2012-08-27
ZA201008584B (en) 2012-01-25
RU2538694C2 (ru) 2015-01-10
MX2010013733A (es) 2011-01-21
CN102099056A (zh) 2011-06-15
WO2009154304A3 (en) 2010-12-02
JP5441934B2 (ja) 2014-03-12
CO6280502A2 (es) 2011-05-20
BRPI0915427A2 (pt) 2015-11-03
CN102099056B (zh) 2014-10-01
PT2285413E (pt) 2012-09-07
ES2389583T3 (es) 2012-10-29
UA100164C2 (ru) 2012-11-26
TW201006800A (en) 2010-02-16
AR072212A1 (es) 2010-08-11
WO2009154304A2 (en) 2009-12-23
NZ589517A (en) 2012-09-28
PL2285413T3 (pl) 2013-01-31
AU2009261101B2 (en) 2013-11-07
CY1113214T1 (el) 2016-04-13
RU2011101713A (ru) 2012-07-27
TWI495634B (zh) 2015-08-11
EP2285413B1 (en) 2012-08-08
EP2285413A2 (en) 2011-02-23
IL209329A (en) 2014-09-30
CA2725487A1 (en) 2009-12-23
SI2285413T1 (sl) 2012-09-28
US20110124682A1 (en) 2011-05-26
JP2011524854A (ja) 2011-09-08

Similar Documents

Publication Publication Date Title
HRP20120644T1 (hr) Farmaceutski pripravak
BRPI0916191A2 (pt) Formas sólidas de (2s, 3r, 4r, 5s, 6r) -2-(4-cloro -3-(4-etoxibenzil) fenil) -6-(metiltio) tetra-hidro-2h-piran -3,4,5- triol e métodos de seu uso
BR112015000320A2 (pt) composições farmacêuticas dissuasivas de abuso, de liberação prolongada
WO2014186742A3 (en) Anhydrous hydrogel composition
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
BR112015011036A2 (pt) derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
BR112013018920A2 (pt) composições de nanopartículas, formulações destas e seus usos
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
GEP201706780B (en) Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
BR112015022861A2 (pt) inibidores de bromodomínio
BR112015022643A2 (pt) inibidores diidro-pirrolpiridinona
BR112015014592A2 (pt) composto, composição farmacêutica, e, método para o tratamento de um humano
BR112015000615A2 (pt) purinas macrocíclicas para o tratamento de infecções virais
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
BR112013032774A2 (pt) métodos para tratar e prevenir infecções por staphylococcus aureus e condições associadas
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
GT200600520A (es) Agentes antibacterianos
BR112014025711A2 (pt) composto, medicamento, e, uso de um composto
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
BR112015006726A2 (pt) Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
CO2018004323A2 (es) Una composición que comprende dihidrato de n4–(ciclopropilmetil)–6– [(3r)–3–(metilamino)pirrolidin–1–il]pirimidin–2,4–diamina tartrato
CL2012001402A1 (es) Composicion farmaceutica en suspension oftalmica acuosa de administracion topica que comprende polimero de carboxivinilo, galactomanana, borato, compuesto en nanoparticulas escasamente soluble, agentes para ajustar ph y tonicidad, conservante y quelante; metodo para tratar trastornos oftalmicos, metodo para mantener viscosidad.
MX2013003635A (es) Compuestos de n-heteroarilo.